4 ms·
Did you read the end of the article? Big pharma's concern is not the market size but the PR fallout from producing a vaccine that causes some users to buy 5x mo
by dfc 15y ago
Did you read the end of the article? Big pharma's concern is not the market size but the PR fallout from producing a vaccine that causes some users to buy 5x more coke than they had in the past.
Why would there be enough demand for the drug to create funds from VCs and grants but nor enough demand for big pharma to do something? I have no idea about Phase 3 requirements but I imagine it is not a friendly to startups.
- mbreese 15y agoI read the entire article... they speculate that the concern of pharma is PR, but really, their guess is as good as mine as to why someone won't manufacture it.